The Antibody Technology Shared Resource at the Fred Hutch Cancer Research Center offers custom antibody development to academic and industrial research groups. Our unique multiplex screening platform incorporates a Molecular Devices ClonePix 2 for identifying and picking monoclonal hybridoma colonies that secrete antibody to specific protein, peptide, or small molecule targets. The ClonePix 2 has allowed us to completely redefine our project workflow and capacity.
Automatically screen more clones in less time than conventional techniques, select cells with optimal expression levels, and pick colonies with accuracy with the ClonePix™ 2 System. ClonePix Systems are now used in over 100 laboratories around the world to increase workflow productivity, leaving more time to better characterize target proteins and run new projects. A large number of biopharma companies have implemented ClonePix Systems in their routine use and data are cited increasingly in scientific publications and conferences.